文献速递血栓与止血

儿童期预防治疗对重型血友病A青年结局的影响:联合结局延续研究结果

Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study.
PubMed 文献 · Blood Adv · 2020-01-01

联合结局研究(JOS)显示2.5岁前开始预防性凝血因子VIII治疗的重型血友病A患儿6岁时关节损伤较按需治疗者减少。联合结局延续研究(JOS-C)以观察性、部分回顾性设计随访JOS参与者至18岁,发现延迟预防组MRI骨软骨损伤发生率77%高于早期预防组35%,年化出血率延迟组10.6±6.6高于早期组3.5±2.1。

要点

  • JOS-C随访至18岁,延迟预防组MRI骨软骨损伤发生率为77%,早期预防组为35%。
  • 延迟预防组与早期预防组骨软骨损伤的比值比为6.3(95%CI 1.3-29.9,P=0.02)。
  • 延迟预防组年化出血率10.6±6.6高于早期预防组3.5±2.1(P<0.001)。

核心结论

  • 在重型血友病A中,与延迟启动预防相比,早期启动预防在整个儿童期持续提供关节损伤保护,但早期预防不足以完全预防损伤。

研究设计与样本

  • JOS-C为观察性、部分回顾性研究,随访JOS参与者至18岁,评估早期与延迟预防对长期关节健康的影响。
  • 65名JOS参与者中37名入选JOS-C,包括15名随机分配至预防组(平均年龄1.3岁开始,为早期预防)、18名初始随机分配至按需治疗组(平均年龄7.5岁开始延迟预防)及4名高滴度抑制物患者。
  • 主要结局为索引关节磁共振成像(MRI)骨软骨损伤评分,次要结局包括关节体格检查评分及关节/其他出血发作的年化率。

主要发现

  • JOS-C结束时,延迟预防组MRI骨软骨损伤发生率为77%,早期预防组为35%。
  • 延迟预防组相对早期预防组的骨软骨损伤比值比为6.3(95%CI 1.3-29.9,P=0.02)。
  • 延迟预防组年化出血率为10.6±6.6,高于早期预防组的3.5±2.1(P<0.001)。
  • 仅比较预防治疗期间的时间段,延迟预防组年化出血率为6.2±5.3,仍高于早期预防组的3.3±1.9(P<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Joint Outcome Study (JOS), a randomized controlled trial, demonstrated that children with severe hemophilia A (HA) initiating prophylactic factor VIII (FVIII) prior to age 2.5 years had reduced joint damage at age 6 years compared with those treated with episodic FVIII for bleeding. The Joint Outcome Continuation Study (JOS-C) evaluated early vs delayed prophylaxis effects on long-term joint health, following JOS participants to age 18 years in an observational, partially retrospective study. Index joint magnetic resonance imaging (MRI) scores of osteochondral (OC) damage (primary outcome), joint physical examination scores, and annualized rates of joint/other bleeding episodes (secondary outcomes) were collected. Thirty-seven of 65 JOS participants enrolled in JOS-C, including 15 randomized to prophylaxis at mean age 1.3 years ("early prophylaxis"); 18 initially randomized to episodic treatment, starting "delayed prophylaxis" at mean age 7.5 years; and 4 with high-titer inhibitors. At JOS-C exit, MRI OC damage was found in 77% of those on delayed and 35% of those on early prophylaxis for an odds ratio of OC damage, in the delayed vs early prophylaxis group, of 6.3 (95% confidence interval, 1.3, 29.9; P = .02). Annualized bleeding rates were higher with delayed prophylaxis (mean plus or minus standard deviation, 10.6 ± 6.6 vs 3.5 ± 2.1; P < .001), including when only comparing time periods on prophylaxis (6.2 ± 5.3 vs 3.3 ± 1.9; P < .05). In severe HA, early initiation of prophylaxis provided continued protection against joint damage throughout childhood compared with delayed initiation, but early prophylaxis was not sufficient to fully prevent damage. This trial was registered at www.clinicaltrials.gov as #NCT01000844.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Warren BB, Thornhill D, Stein J, et al. Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study. Blood Adv. 2020. PMID: 32492157. doi:10.1182/bloodadvances.2019001311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。